Ophthotech Corp. to Report Fourth Quarter & Full Year 2018 Financial Results & Host Conference Call on Tuesday, February 26, ...
February 19 2019 - 8:00AM
Business Wire
Ophthotech Corporation (Nasdaq: OPHT) today announced that it
will report its fourth quarter and full year 2018 financial and
operating results on Tuesday, February 26, 2019. Following the
announcement, Ophthotech’s management team will host a live
conference call and webcast at 8:00 a.m. Eastern Time to discuss
the Company’s financial results and provide a general business
update.
To participate in this conference call, dial 888-224-1005 (USA)
or 323-994-2093 (International), passcode 6840989. A live,
listen-only audio webcast of the conference call can be accessed on
the Investor Relations section of the Ophthotech website at:
www.ophthotech.com. A replay will be available approximately two
hours following the live call for two weeks. The replay number is
888-203-1112 (USA Toll Free), passcode 6840989.
About Ophthotech Corporation
Ophthotech is a biopharmaceutical company specializing in the
development of novel therapies for diseases of the eye. For more
information, please visit www.ophthotech.com.
Forward-looking Statements
Any statements in this press release about Ophthotech's future
expectations, plans and prospects constitute forward-looking
statements for purposes of the safe harbor provisions under the
Private Securities Litigation Reform Act of 1995. Actual results
may differ materially from those indicated by such forward-looking
statements as a result of various important factors. Any
forward-looking statements represent Ophthotech's views only as of
the date of this press release. Ophthotech anticipates that
subsequent events and developments will cause its views to change.
While Ophthotech may elect to update these forward-looking
statements at some point in the future, Ophthotech specifically
disclaims any obligation to do so.
OPHT-G
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190219005045/en/
InvestorsKathy GalanteOphthotech CorporationVice
President, Investor Relations and Corporate
Communications212-845-8231kathy.galante@ophthotech.com
MediaAlex Van ReesSmithSolve LLC on behalf of Ophthotech
Corporation973-442-1555 ext. 111alex.vanrees@smithsolve.com
OPHTHOTECH CORP. (NASDAQ:OPHT)
Historical Stock Chart
From Aug 2024 to Sep 2024
OPHTHOTECH CORP. (NASDAQ:OPHT)
Historical Stock Chart
From Sep 2023 to Sep 2024